Response Genetics (RGDXQ) Stock Statistics & Valuation Metrics
Total Valuation
Response Genetics has a market cap or net worth of $39.00. The enterprise value is ―.
- Market Cap
- $39.00
- Enterprise Value
- ―
Share Statistics
Response Genetics has 38,795,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 38,795,000
- Owned by Insiders
- ―
- Owned by Institutions
- 15.47%
Financial Efficiency
Response Genetics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- 187.92K
- Profits Per Employee
- -210.25K
- Employee Count
- 96
- Asset Turnover
- ―
- Inventory Turnover
- ―
Valuation Ratios
The current PE Ratio of Response Genetics is 0.00. Response Genetics’s PEG ratio is ―.
- PE Ratio
- 0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- ―
Income Statement
In the last 12 months, Response Genetics had revenue of 18.04M and earned -20.18M in profits. Earnings per share was 0.00.
- Revenue
- 18.04M
- Gross Profit
- 3.94M
- Operating Income
- -21.38M
- Pretax Income
- -21.37M
- Net Income
- -20.18M
- EBITDA
- -19.67M
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -13.09M and capital expenditures -51,425, giving a free cash flow of -13.14M billion.
- Operating Cash Flow
- -13.09M
- Free Cash Flow
- -13.14M
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Response Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -380000.00%
- Earnings Yield
- ―
Stock Price Statistics
- Beta
- 0.28
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Taxes
In the past 12 months, Response Genetics has paid -1.18M in taxes.
- Income Tax
- -1.18M
- Effective Tax Rate
- ―
Enterprise Valuation
Response Genetics EV to EBITDA ratio is 0.67, with an EV/FCF ratio of 0.89.
- EV to Sales
- -0.73
- EV to EBITDA
- 0.67
- EV to Free Cash Flow
- 0.89
- EV to Operating Cash Flow
- 0.96
Balance Sheet
Response Genetics has $9.09M in cash and marketable securities with $0.00 in debt, giving a net cash position of $9.09M billion.
- Cash & Marketable Securities
- $9.09M
- Total Debt
- $0.00
- Net Cash
- $9.09M
- Net Cash Per Share
- $0.23
- Tangible Book Value Per Share
- ―
Margins
Gross margin is 21.85%, with operating margin of -118.50%, and net profit margin of -111.88%.
- Gross Margin
- 21.85%
- Operating Margin
- -118.50%
- Pretax Margin
- -118.45%
- Net Profit Margin
- -111.88%
- EBITDA Margin
- -109.01%
- EBIT Margin
- -116.54%